Literature DB >> 31413791

Inhibition of ACSS2 for Treatment of Cancer and Neuropsychiatric Diseases.

Robert B Kargbo1.   

Abstract

Entities:  

Year:  2019        PMID： 31413791      PMCID： PMC6691481          DOI： 10.1021/acsmedchemlett.9b00295

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  2 in total

1.  Sirtuins: a conserved key unlocking AceCS activity.

Authors:  Brian J North; David A Sinclair
Journal:  Trends Biochem Sci       Date:  2006-12-01       Impact factor: 13.807

Review 2.  Acylation of Biomolecules in Prokaryotes: a Widespread Strategy for the Control of Biological Function and Metabolic Stress.

Authors:  Kristy L Hentchel; Jorge C Escalante-Semerena
Journal:  Microbiol Mol Biol Rev       Date:  2015-07-15       Impact factor: 11.056
  2 in total
  4 in total

Review 1.  Acetyl-CoA synthetase 2(ACSS2): a review with a focus on metabolism and tumor development.

Authors:  Rui Ling; Gong Chen; Xiang Tang; Na Liu; Yuepeng Zhou; Deyu Chen
Journal:  Discov Oncol       Date:  2022-07-07

2.  Squalene through Its Post-Squalene Metabolites Is a Modulator of Hepatic Transcriptome in Rabbits.

Authors:  Roubi Abuobeid; Javier Sánchez-Marco; María J Felices; Carmen Arnal; Juan Carlos Burillo; Roberto Lasheras; Rebeca Busto; Miguel A Lasunción; María Jesús Rodríguez-Yoldi; Roberto Martínez-Beamonte; Jesús Osada
Journal:  Int J Mol Sci       Date:  2022-04-10       Impact factor: 6.208

Review 3.  Targeting cancer metabolism in the era of precision oncology.

Authors:  Zachary E Stine; Zachary T Schug; Joseph M Salvino; Chi V Dang
Journal:  Nat Rev Drug Discov       Date:  2021-12-03       Impact factor: 84.694

Review 4.  Mitochondrial Genetic and Epigenetic Regulations in Cancer: Therapeutic Potential.

Authors:  Alexandra Wagner; Helena Kosnacova; Miroslav Chovanec; Dana Jurkovicova
Journal:  Int J Mol Sci       Date:  2022-07-18       Impact factor: 6.208
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.